MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today reported financial results for the three and nine months ended September 30, 2014.
Highlights of the third quarter of 2014 and recent weeks include:
•Commercially launched NexoBrid in the Nordic countries, Austria, Slovak Republic, Spain and Israel.
Help employers find you! Check out all the jobs and post your resume.
